Preeclampsia is characterised by high blood pressure and signs of damage to other organs.

A Cork-based biotechnology company has secured €2 million in funding to develop a product to identify whether women could develop preeclampsia. Meta(...)

Dr Barbara Murphy, Head of Equine Science, UCD

Innovation is the lifeblood of science, but it doesn’t come cheap. Solid research and development costs money, but the economic and social returns on (...)

 Pictured  with 4 day old baby Molly, are Enterprise Equity partner Frank Walsh, Partner,  SOSventures European Investment Partner Bill Liao, Metabolomic Diagnostics chief executive Charles Garvey and Prof. Louise Kenny, consultant obstetrician and director of the INFANT Centre.

Irish biotech company Metabolomic Diagnostics has secured an additional $2 million in venture funding to help complete its new screening test for firs(...)

The Mayo Clinic and Enterprise Ireland have formalised a collaboration which will see the commercialisation of up to 20 medical technologies in Ireland over the next five years

Irish biotech start-up Inform Bioscience is to sign a licence agreement tomorrow with the world-renowned Mayo Clinic to acquire a portfolio of biomark(...)

Charles Garvey: said the company’s focus now is on the final testing and validation of its product

According to the World Health Organisation, there is no reliable, cost-effective screening test to detect the potentially life-threatening condition i(...)